Introduction to Levothyroxine and Its Use
Levothyroxine is a popular thyroid medication taken by approximately 23 million Americans to treat hypothyroidism.
While it effectively regulates thyroid hormone levels, recent research from Johns Hopkins has raised concerns about its long-term impact on bone health.
Study Findings on Bone Density Loss
The study conducted involved 445 participants, who were an average of 73 years old.
Over a six-year period, researchers found that those taking levothyroxine experienced significant bone density loss, even when their thyroid levels were considered normal.
This raises alarms about the medication’s role in accelerating bone loss, particularly among older adults.
Risks of Osteoporosis and Overprescription
Osteoporosis is a condition that affects approximately 10 million Americans and poses a serious risk of fractures and early mortality.
Alarmingly, the research findings suggest that levothyroxine is often overprescribed, with about 90% of its users potentially not requiring it.
Patients currently using the drug are encouraged to reassess their treatment plans and monitor their thyroid function regularly.
These actions are crucial for ensuring bone health and reducing the likelihood of osteoporosis.